LATEST DEAL TYPE
LATEST DEAL AMOUNT
Developer of a regenerative medical technology platform using silk. The company is developing silk-based biomaterials designed to help regenerate human tissues, including in the vascular system, and then to degrade and be safely absorbed in the body.
Privately Held (backing)
Other Healthcare Technology Systems
Via Cavour 2
Questions or concerns about this profile? Reach out to email@example.com